DEBORAH PRATHER: Open Payments
NPI 1063690964 · GRIFFIN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$206 in 10 payments from 6 companies in 2025. Trend: 2023 $1,721 · 2024 $1,017 · 2025 $206
Food & beverage: $206
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Amgen Inc. | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
| PFIZER INC. | 1 | $20 |
Products named: Ozempic, OTEZLA, Kerendia, JARDIANCE, ELIQUIS, AIRSUPRA, FARXIGA.
Industry payments across GA — which companies pay providers there.
